Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures
Abstract Aim: This prospective, multicenter, open-label, noninterventional 12-week study investigated the effectiveness and tolerability of add-on nabiximols oromucosal spray (Sativex®)…
